Ligand-bound nuclear receptors (NRs) recruit cofactors such as members of the p160 family and CREB-binding protein (CBP) to activate transcription. We have cloned the Xenopus homologue of the human transcription intermediary factor 2 (TIF2), a member of the p160 family of cofactors. Xenopus TIF2 (XTIF2) mRNA is expressed homogeneously during late blastula±early gastrula stages and later becomes highly expressed in the notochord. To study the function of XTIF2 during development, we have used two dominant negative constructs, one encompassing the NR-binding domain and the other the CBP interacting region of XTIF2. Overexpression of the XTIF2 dominant negative mRNAs causes ectopic expression of Xenopus Brachyury (Xbra) and MyoD in all tissue layers. Moreover, ectopic expression of the dominant negative construct that contains the CBP-binding region produces strong phenotypes at hatching stage such as loss of head structures, shortened trunks and open blastopores, which can be rescued by XTIF2 coexpression. These observed defects are due, at least in part, to repression of dorsal mesoderm and endoderm genes. Our data suggest the existence of a NR pathway that requires XTIF2 and CBP to repress Xbra and XMyoD. q
Introduction
During the last few years it has been shown that nuclear receptors (NRs), in response to hormone-binding, recruit distinct cofactors, including the p160 family of coactivators, CREB-binding protein (CBP)/p300, and p300/CBP-associated factor (p/CAF), to form functional complexes that are required for the activation of transcription mediated by those NRs. Most of these coactivators have histone acetyltransferase (HAT) activity and therefore may act cooperatively to remodel chromatin (reviewed in Freedman (1999) ; Xu et al. (1999) ).
The p160 coactivators (ACTR, p/CIP, SRC-1/NCoA-1, TIF-2/GRIP-1/NCoA-2, TRAM-1, RAC3 and AIB1) were identi®ed as ligand-dependent coactivators of NRs (Voegel et al., 1996; Yao et al., 1996; Anzick et al., 1997; Chen et al., 1997; Hong et al., 1997; Li et al., 1997; Takeshita et al., 1997; Torchia et al., 1997) . However, they can also participate in transcriptional activation mediated by other transcription factors (Torchia et al., 1997; Korzus et al., 1998) . All the p160 family members share similar structures. Besides the HAT domain present in many of them, they all have a PAS/bHLH domain, a NR interaction region and a CBP/p300-binding domain. Northern analyses of most of the mRNAs encoding these coactivators indicate that they are expressed differentially in several adult tissues. The functional analysis of these cofactors has been performed mainly in cell-culture systems or by using the yeast twohybrid system. These experiments have shown that both the NR interaction region and the CBP-binding region are necessary for their function as coactivators for NRs. Thus, removing the NR interaction region blocks their ability to increase the activation of transcription mediated by NRs (Heery et al., 1997) . Similarly, peptides or protein fragments encompassing the NR interaction region or the CBP-binding domain interfere with the activation of transcription mediated by the wild-type proteins (Torchia et al., 1997; Voegel et al., 1998) . Therefore, binding of p160 coactiva-tors to NR and CBP is essential for their function. The NR interaction region of these cofactors contains several characteristic motifs (i.e. LXXLL, where L is leucine) necessary for their binding to NR. Mutation of these elements strongly impairs their binding to NRs and coactivation activity (Heery et al., 1997; Torchia et al., 1997; McInerney et al., 1998; Voegel et al., 1998) . Similarly, the CBP-binding region of the p160 family of cofactors contains another leucine motif (LLXXLXXXL) which is important for CBP-binding and transcriptional coactivation (Torchia et al., 1997; Voegel et al., 1998) . In contrast, the PAS/bHLH domain seems to be dispensable for coactivator function (Li et al., 1997) . Several of these coactivators have been shown to bind pCAF Spencer et al., 1997; Torchia et al., 1997) , which seems to be an important component of the coactivator complex for several transcription factors (Korzus et al., 1998) .
Among the p160 family of coactivators, Transcription Intermediary Factor 2 from human (TIF2) or the mouse ortholog (GRIP1/NcoA-2) has been shown to bind and mediate transcriptional activation of several NRs such as retinoic (RAR and RXR), oestrogen (ER), thyroid (TR), vitamin D3 (VDR), glucocorticoid (GR), androgen (AR) and progesterone (PR) receptors (Hong et al., 1997; Voegel et al., 1996 Voegel et al., , 1998 . Indeed, TIF2 mutant forms lacking a nuclear localization signal are targeted to the nucleus upon NR interaction (Voegel et al., 1996) . TIF2/ GRIP1/ NcoA-2 is expressed in several adult mammalian tissues such as pancreas, kidney, muscles, liver, lung, placenta, brain, heart and testis, but the expression levels vary among those tissues. In addition, HAT activity has not been identi®ed in these cofactors.
In Xenopus only one member of the p160 family of cofactors has been described to date (Han-Jong et al., 1998) . This cofactor, XSRC-3, binds and stimulates transcription of several ligand-bound nuclear receptors such as RAR, RXR, TR, hepatocyte nuclear receptor 4 and constitutive androstane receptor. This gene is expressed in oocytes and adult liver. XSRC-3 LXXLL motifs are also essential for NR-binding and for hormone-bound NR activation of downstream promoters. In addition, XSRC-3-binding to CBP is necessary for its coactivation function (Han-Jong et al., 1998) . Thus, although many members of the p160 family of coactivators have been identi®ed and their function has been elucidated in cell-culture experiments, their expression patterns and function during development have not been determined.
In this work we report the identi®cation of the Xenopus homologue of human TIF2 (XTIF2). XTIF2 has a dynamic pattern of expression with homogeneous mRNA distribution in late blastula±early gastrula stages and strong levels in the notochord at the late gastrula and neurula stages. At the hatching stage, XTIF2 is restricted to a few areas such as the blood precursor region, prospective pronephros and retina. We have generated two dominant negative forms of XTIF2. Functional analysis of these dominant negative proteins indicate that this cofactor participates in the suppression of Xbra and XMyoD expression through a nuclear receptor pathway which also requires CBP.
Materials and methods

Molecular cloning of the XTIF2 gene
Approximately 10 6 phages from a Xenopus gastrula (stages 10.5±11.5) UniZap-XR cDNA library (Cho et al., 1991) were screened at low stringency with a Drosophila abrupt probe, in hybridization buffer (40% formamide, 4£ SSC, 5£ Denhardt's, 0.1% SDS, 20 mM phosphate buffer (pH 6.8), 0.1mg/ml salmon sperm DNA and 0.1% sodium pyrophosphate) at 428C. Filters were washed with 2£ SSC, 0.1% SDS at 428C. Seven positives were obtained, were puri®ed and the corresponding plasmids were excised. Unexpectedly, one of the cDNAs (4.3 kb) encoded the Xenopus homologue of the human TIF2 gene. Since this cDNA was 5
H truncated, we used the RACE method to obtain the complete cDNA. To that end we used the Clontech Marathon cDNA ampli®cation KIT. The XTIF2 speci®c oligonucleotide 5 H -GCCAAGCCCATTTGTTCC-3 H was used to generate a cDNA library enriched in XTIF2. This library was used in a polymerase chain reaction (PCR) with the supplied AP1 oligonucleotide and the XTIF2-speci®c primer 5
H -GGACTGCTGGACTGAACTGGATTTAAT-GTC-3
H which allowed us to obtain a 1.3 kb RACE fragment that was fused to the original cDNA using a XbaI restriction site present in both the original and RACE cDNAs and a NotI site present in the AP1 primer. The resulting 4.9 kb full-length cDNA has an open reading frame (ORF) which encodes a protein of 1519 amino acids with a strong similarity to the human and mouse TIF2/GRIP-1/NcoA-2 cofactors.
Dominant negative XTIF2 constructs
The 5 H -GCAGAAAGAATTCGGTG-3 H and 5 H -GCT-CGCTCTAGATTGGG-3 H and the 5 H -GAGTGAATTC-CCCTAGGC-3 H and 5 H -CAGGATCTAGAATTGGTTG-3 H primers were used in different PCRs to amplify the regions encompassing the NR and CBP XTIF2-binding regions, respectively. These PCR fragments were cloned in pCS21-NLS-MT (Turner and Weintraub, 1994) using the EcoRI and XbaI sites at their ends and then were fully sequenced.
DNA sequencing
Sequencing was performed in an automatic DNA sequencer using ABI chemistry and T3, T7 and custom synthesized oligonucleotides (ISOGEN Bioscience B.V., Maarssen, The Netherlands) as primers. Consensus sequences were assembled and analysed with the University of Wisconsin GCG software packages (Devereux et al., 1984) .
Whole-mount in situ hybridization and X-Gal staining
Antisense RNA probes were prepared from XTIF2, Xbra (Smith et al., 1991) , pintallavis (Ruiz i Altaba and Jessell, 1992), Xlim1 (Taira et al., 1992) , XMyoD (Hopwood et al., 1989) , cerberus (Bouwmeester et al., 1996) , gsc (Cho et al., 1991) , Xotx (Blitz and Cho, 1995; Artinger et al., 1997) , endodermin , chordin (Sasai et al., 1994) and Mix.1 (Rosa, 1989) cDNAs and labelled with digoxigenin. Specimens were prepared, hybridized and stained by the method of Harland (1991) with modi®cations (Mancilla and Mayor, 1996) .
In vitro RNA synthesis
All the vectors were linearized and transcribed as described by Harland and Weintraub (1985) with GTP cap analogue (New England Biolabs). SP6, T3 or T7 RNA polymerases were used. After DNAse treatment, RNA was extracted with phenol±chloroform and precipitated with ethanol. mRNA to be injected was resuspended in water at the proper concentration.
Embryos, explants, conjugates and microinjections
Xenopus embryos were obtained as described previously (Mayor et al., 1993) and staged according to Niewkoop and Faber (1967) . Animal caps were prepared as previously described (Go Âmez-Skarmeta et al., 1998) . Synthetic mRNAs were injected into embryos at the 1-or 2-cell stage using 8±12 nl as in Go Âmez-Skarmeta et al. (1998) .
Results
Molecular cloning of Xenopus TIF2
In a low-stringency screen of a Xenopus gastrula (stages 10.5±11.5) cDNA library using a Drosophila abrupt probe we fortuitously identi®ed a 4.3 kb cDNA clone encoding a 3 H fragment of a Xenopus member of the p160 family of cofactors. We cloned the remaining 5 H region of the mRNA using the RACE technique (Frohman et al., 1988) . The longest (1.3 kb) RACE fragment was fused to the original cDNA using a XbaI restriction site present in both the original and RACE cDNAs. The resulting 4.9 kb full-length cDNA has an ORF which encodes a protein of 1519 amino acids very similar to the human and mouse TIF2/GRIP-1/NcoA-2 cofactors (Voegel et al., 1996; Hong et al., 1997; Torchia et al., 1997) (Fig. 1) . Thus, we have named this protein XTIF2. XTIF2 has all of the characteristic features of a Fig. 1 . Comparison between Xenopus and human TIF2 proteins (accession numbers AJ243119, X97674). The blue region corresponds to the bHLH/ PAS domain. The red sequence comprises the NR-binding region identi®ed in human TIF2. Three LXXLL motifs are found within this region and are denoted by green boxes. These motifs are necessary for TIF2-binding to NRs (Voegel et al., 1998) The green domain contains the CBP-binding region. A leucine-rich domain that is highly conserved between the p160 family of cofactors (Voegel et al., 1998 ) is highlighted in orange. This region corresponds to an activating domain found in human TIF2. The second human TIF2 activating domain is shown in purple (Voegel et al., 1998) . Arrowheads below the protein sequence show the regions used to obtain the dominant negative XTIF2 constructs. p160 cofactor such as the PAS/bHLH domain, the NR and CBP interaction regions and the carboxy-terminal activation domain. As is the case with TIF2/GRIP-1/NcoA-2, three LXXLL motifs are found within the NR interacting region. The CBP-binding region contains a different leucine-rich motif (LLXXLXXXL) highly conserved among the p160 family of cofactors (Voegel et al., 1998) (Fig. 1) .
Expression pattern of XTIF2
The expression pattern of XTIF2 was determined by whole-mount in situ hybridization. At late blastula (stage 9 embryos; Niewkoop and Faber, 1967) , XTIF2 expression is detected in the animal region ( Fig. 2A) . At the beginning of gastrulation (stage 10) the expression of XTIF2 is generalized, although higher levels are found dorsally (Fig. 2B ). Since expression of XTIF2 is quite faint and usually gene expression is hard to detect in the endoderm (see for example Mix.1 (Lemaire et al., 1998) ), we also performed reverse transcription (RT)±PCR to ectoderm, mesoderm and endoderm dissected from stage 10 embryos. In these experiment we detected XTIF2 expression in all three germ layers (not shown). Closer examination of XTIF2 mRNA expression in the dorsal mesoderm, and comparison with goosecoid mRNA localization (not shown), indicate that it is present in all the prospective axial mesoderm region including the head mesoderm (Fig. 2C, arrowhead) . At late gastrula (stage 12.5), expression of XTIF2 in the notochord becomes stronger ( Fig. 2D, arrowhead) . At mid neurula (stage 16), besides the expression in the notochord, XTIF2 mRNA is detected in the lateral epidermis and low levels become apparent in the anterior region of the embryo (Fig. 2E ). Examination of sagittal and transverse sections indicates that XTIF2 is expressed in the prechordal mesoderm (Fig. 2F , arrowhead), notochord (Fig. 2G, arrowhead) and weakly in the neuroectoderm and lateral mesoderm (Fig. 2G , black and white arrows, respectively). This pattern is maintained along the neurula stage ( Fig. 2H ) and is clearly observed in sagittal and transverse sections of stage 20 embryos (Fig. 2I, J) . At this stage strong expression of XTIF2 can be detected in the head (Fig. 2H, arrowhead) . In hatching stage embryos (stage 35) XTIF2 become strongly expressed in the prospective eye lens (Fig. 2K ,L, arrowheads), pronephros (Fig. 2K , white arrow) and ventral blood vesicles ( Fig. 2K and inset, black arrows).
Interference with XTIF2 function causes strong embryonic defects
In order to determine the function of XTIF2, we injected different concentrations of its mRNA into one cell stage embryos. We did not observe any detectable phenotype in embryos injected with up to 4 ng of XTIF2 RNA (Fig. 3A) .
In an attempt to interfere with XTIF2 function we created two constructs which produce RNAs encoding dominant negative forms of the protein. These consist of truncated versions of XTIF2 which encode the regions encompassing only the NR (DNN) or CBP (DNC) interacting domains, respectively. These protein fragments have been shown to interfere with the transcriptional coactivation capability of full-length p160 coactivators in cellculture assays (Torchia et al., 1997; Voegel et al., 1998) . The truncated forms of XTIF2 were fused in frame to a Myc tag sequence in the pCS21-NLS-MT vector (Turner and Weintraub, 1994) to allow us to detect the presence of the fusion protein. Injection of 2 ng of RNA of the DNN construct at the one cell stage caused phenotypes in about 30% (n 53) of hatching-stage embryos. These showed lack of head structures, short trunks and open blastopores (not shown). Injection of 2 ng of RNA of the DNC construct elicited a similar phenotype compared to the DNN construct but the defects were much more pronounced and penetration was much higher. Thus, 8% of the injected embryos showed weak defects, 22% medium defects and 70% very strong defects, as shown in Fig. 3B (n 78). Since embryos injected with the DNC construct overexpress a CBP interacting domain, it is possible that the phenotype observed in these injected embryos could be due to the interference with other cofactors or transcriptional factors that also require CBP. To test the speci®city of the observed phenotypes we coinjected one cell-stage embryos with 2 ng of the DNC construct RNA and 2 ng of the full-length XTIF2 mRNA. As shown in Fig. 3C , coinjection of both mRNAs largely rescues the phenotype observed in embryos injected with DNC alone. Thus, only 7% of these embryos showed strong defects such as those in Fig. 3B , 36% were partially rescued as the upper embryo in Fig. 3C and the remaining 57% were almost completely rescued as the two lower embryos shown in Fig. 3C (n 56). These results indicate that most of the observed phenotype is indeed due to partial loss of XTIF2 function. However, it is still possible that the observed phenotype is caused by interference with the function of another p160 coactivator which is overcome by XTIF2 overexpression. To test this, we coinjected 2 ng of the DNC construct RNA with 2 ng of XSRC-3 mRNA which encodes another member of the Xenopus p160 family of cofactors (Han-Jong et al., 1998) . Embryos injected with both mRNAs showed a similar phenotype to those injected with the DNC construct mRNA alone (73% affected, n 41), suggesting that the DNC construct speci®cally interferes with XTIF2 function, and that the effects produced by its overexpression cannot be rescued by a p160 coactivator other than XTIF2 (Fig. 3D) . It is important to note that the phenotype caused by DNC overexpression is dose dependent. Thus, low amounts of DNC RNA (100 pg) produced very mild defects, similar to those caused by injection of 2 ng of DNN RNA and, as the amount of injected DNC RNA is increased, the observed phenotype becomes stronger (not shown). We do not know the reason for the observed difference in the effects between injection of DNN and DNC, but we have observed that the stability of the DNN protein seems very low compared with that of the DNC protein as determined by anti-Myc staining (see below). Therefore, different protein stabilities may explain the differing penetration of the phenotype in embryos injected with DNN or DNC.
XTIF2-dominant negatives upregulate Xbra and XMyoD
Since XTIF2 is strongly expressed in the notochord, we , and the weak expression in the neural tube (white arrowhead) and somites (white arrow). Higher levels of expression are also detected at the boundary between the neural tube and somites (black arrow). (K±L) Hatching embryos (stage 35). (K) XTIF2 expression is stronger in the head with higher levels in the eye lens (arrowheads). XTIF2 mRNA is also detected in the pronephros (white arrow) and in the ventral region of the embryo (black arrow). Inset shows ventral view of this embryo. XTIF2 is expressed in a V-shaped domain (arrow). (L) Section across the eye level of the head showing strong XTIF2 expression in the eye lens (arrowheads). an, animal; vg, vegetal; b, blastopore; d, dorsal; v, ventral; a, anterior; p, posterior. have examined the effects of injecting the two dominant negative constructs on the expression of notochord markers. 2 ng of mRNA encoding the DNN or DNC domains were injected, from here thereafter, at one blastomere at the twocell stage. Since each blastomere of the two-cell stage will give rise to the right and left side of the embryos, respectively, the non-injected side serves as a control. In embryos injected with DNN (100%, n 18) there is a strong activation of Xbra (Smith et al., 1991) in anterior mesoderm and ectoderm/neuroectoderm (Fig. 4D) . In contrast, other notochord markers, such as pintallavis (Ruiz i Altaba and Jessell, 1992) or Xlim1 (Taira et al., 1992) , are not affected (Fig.  4E,F) . DNC-injected embryos also showed similar ectopic expression of Xbra (100%, n 16) (Fig. 4G) . However, in these embryos both pintallavis (77%, n 13) and Xlim1 (80%, n 15) ( Fig. 4H and I, respectively) are repressed and gastrulation is affected, as the blastopore does not close in many cases. Indeed, notochord formation is disrupted and lateral mesoderm is expanded as judged by examinations of sections of these embryos (not shown). Note that in the embryos injected with DNN, Myc staining is weakly visible as opposed to those injected with DNC, despite the longer development time of the Myc-tag in the former embryos (3 h) and the short time in the latter ones (10 min). The effects of DNN and DNC injections on Xbra overexpression were also detected at neurula and tailbud stages (not shown). These results prompted us to examine the effects of XTIF2-dominant negatives injection on early mesoderm formation. We ®rst analysed the expression of lateral and ventral mesoderm markers in the injected embryos at stage 10. As shown in Fig. 5 , XMyoD (Hopwood et al., 1989 ) is also upregulated in embryos injected with 2 ng of DNN (100% n 31) or DNC (100%, n 24) RNA. Both, Xbra and XMyoD are overexpressed in the ectoderm, dorsal mesoderm (XMyoD is not expressed in this territory and Xbra is downregulated in the dorsal endomesoderm due to goosecoid (gsc) (Cho et al., 1991) repression (Artinger et al., 1997; Latinkic et al., 1997) ) and endoderm regions, being the overexpression strongest in DNC injected embryos (compare Fig. 5A and B with Fig. 5C and D, respectively) . However, Xvent1 (Gawantka et al., 1995) and Xvent2 (Onichtchouk et al., 1996) are not upregulated in the injected embryos (not shown).
The strong overexpression of Xbra and XMyoD in the ectoderm made us analyse if the overexpression of the dominant negative constructs was capable of activating these genes in animal caps. Indeed, animal caps from embryos injected with 300 pg of lacZ and 2 ng of DNN mRNAs did express both Xbra and XMyoD (100% caps expressing lacZ, n 12) (Fig. 5E,F) . Note that those caps that are negative for b -galactosidase do not express Xbra or XMyoD. Similar results were obtained with caps of embryos injected with 2 ng of DNC mRNA.
Xbra expression is controlled by several enhancers. An enhancer responsible for Xbra expression in the mesoderm but not in the notochord has been identi®ed by two groups (Artinger et al., 1997; Latinkic et al., 1997) . This enhancer promotes expression of Xbra in the mesoderm in response to FGF and activin at the onset of gastrulation and later restricts Xbra expression to the posterior mesoderm (Latinkic et al., 1997) . To determine if overexpression of the dominant negative proteins are indeed activating Xbra through this enhancer we injected embryos with 150 pg of the 2.1 kb Xbra DNA promoter, which contain the mentioned enhancer, driving the luciferase gene (Latinkic et al., 1997) with or without 2 ng of the DNC RNA. The expression of luciferase and Xbra was assayed at stage 10.5 (Fig. 5G,H ). Embryos injected with DNC RNA strongly express luciferase and some expression can also be detected in the endoderm, similarly to the endogenous Xbra expression (Fig. 5H ). This ectopic expression was not observed in those embryos injected only with the Xbra promoter-luciferase DNA (Fig. 5G) . In addition, these embryos showed lower levels of luciferase mRNA. These data suggest that XTIF2 is necessary to repress Xbra, and that this repression takes place through the Xbra enhancer that directs its expression in the mesoderm but not in the notochord. It is possible that, as a consequence of Xbra overexpression, XMyoD is upregulated.
Dominant negative XTIF2 represses dorsal mesoderm genes
Overexpression of XTIF2 DNC, and to a lower extent DNN RNAs, caused a strong impairment of anterior development. To explore the cause of this phenotype we have analysed the effect of overexpressing DNC RNA on dorsal mesoderm markers. Similar results were obtained when the detection of the DNC protein was done by anti-Myc staining, and when we coinjected DNC and lacZ mRNAs and performed XGal staining. Fig. 6 shows the effect on different dorsal markers (stage 10) of injecting 2 ng of DNC RNA alone or together with 300 pg of lacZ mRNA into the dorsal region of one blastomere of the two-cell stage. Both dorsal mesoderm markers, such as chordin (chr) (Sasai et al., 1994) , gsc and Xotx2 (Blitz and Cho, 1995; Pannese et al., 1995) , and dorsal endoderm markers, like cerberus (cer) (Bouwmeester et al., 1996) , endodermin (edd) and Mix.1 (Rosa, 1989) are clearly repressed in the injected side (68%, n 25; 85%, n 21; 92%, n 13; 91%, n 12; 75%, n 12 and 80%, n 21, respectively). In contrast, embryos injected with 2 ng of DNN RNA only occasionally showed a reduction in dorsal mesoderm and endoderm markers. These results indicate that the lack of anterior structures in embryos injected with DNC mRNA could be due to repression of dorsal mesoderm and endoderm development.
Discussion
Upon ligand binding, nuclear receptors (NRs) recruit a variety of cofactors which are necessary for the NRmediated activation of transcription. One of these families is collectively called p160 and comprises a group of highly related proteins such as TIF2/GRIP1/NcoA-2, SRC-1/ NcoA-1 and pCIP/ACTR/AIB1 (reviewed in Xu et al., 1999) . In this report we have cloned the Xenopus homologue of human TIF2. XTIF2, similarly to TIF2/GRIP1/ NcoA-2, has several characteristic domains shared with members of the p160 family of cofactors. Thus, XTIF2 has a PAS/bHLH domain in the amino terminal region In these embryos other notochord markers were not affected (pintallavis in E and Xlim1 in F). (G±I) Embryos injected with DNC ectopically express Xbra (G, arrowhead) but pintallavis (H, arrowhead) and Xlim1 (I, arrowhead) are suppressed in the injected half of the embryo. Myc is clearly visible in H and I but is only weakly detectable in E and F.
followed by a NR interacting domain and a CBP-binding region. The NR interacting domain has three LXXLL motifs that are necessary for binding of TIF2 to the ligand-binding domain of activated NRs (Voegel et al., 1998) . The CBPbinding region of XTIF2 displays a leucine motif (LLXXLXXXL) which, when mutated in human TIF2, strongly impairs the transcriptional stimulatory activity of this cofactor and which correlates with a reduced capability to bind CBP (Voegel et al., 1998) . At the carboxy terminus, XTIF2, similarly to human TIF2, has a poly-glutamine-rich region and a region highly similar to the TIF2 carboxyterminal activating domain.
Expression pattern of XTIF2
XTIF2 is detected by in situ hybridization at the late blastula stage and early gastrula stages in a generalized pattern of expression. RT±PCR experiments using RNA from ectoderm, mesoderm and endoderm dissected from stage 10 embryos indicate that, in addition to ectoderm and mesoderm XTIF2 expression, mRNA from this gene is also present in the endoderm. At mid gastrula and early neurula stages XTIF2 begins to be highly expressed in the presumptive notochord region. At this stage, weak expression is detectable in the neuroectoderm and lateral mesoderm. At mid to late neurula, this pattern is maintained, expression of XTIF2 can be detected in the prechordal mesoderm and expression in the head region becomes more apparent. In addition, a salt-and-pepper expression pattern is detectable in the epidermis. At the hatching stages, expression of XTIF2 is present in the head region with stronger levels in the region that will give rise to the lens of the eye. In addition, expression can also be detected in the prospective pronephros and in a ventral V-shape domain that probably corresponds to the future blood precursors. Although mammalian TIF2/GRIP-1/NcoA-2 expression has not been determined by whole-mount in situ hybridization during embryogenesis, Northern analyses showed expression in several adult tissues (Voegel et al., 1996; Hong et al., 1997) such as pancreas, kidney, muscles, liver, lung, placenta, brain, heart and testis. Expression of XTIF2 has not been analysed in fully differentiated tissues and organs. However, as described above, it is expressed in territories that will give rise to some of those tissues and organs, such as the lateral mesoderm, where muscle and heart will form, pronephros, that will form the kidney, and in the head region, that will form the brain. Embryos injected with 150 pg of a 2.1 kb Xbra promoter containing the mesoderm enhancer (but not the notochord) which drives luciferase expression and stained for Xbra (left embryo) or luciferase (right embryo) mRNAs. Note that luciferase staining remains within Xbra domains of expression (right embryo, arrowhead). (H) Embryos as in G but coinjected with 2 ng of DNC mRNA. Note that both Xbra (left embryo) and luciferase (right embryo) are now ectopically expressed in the endoderm (arrowheads). In addition, stronger activation of the Xbra promoter is observed in these embryos (compare with G). In situs in G and H for Xbra and luciferase were developed during similar periods of time.
XTIF2 participates in Xbra and XMyoD repression
Ectopic overexpression of XTIF2 mRNA did not cause phenotypic defects. This suggests that the restricted expression of XTIF2 observed from late gastrula±early neurula and onwards is not essential to restrict the function of the pathway in which XTIF2 participates. Thus, limiting levels of ligand, NR or CBP could help de®ne the domains where this pathway is active. In an attempt to interfere with this pathway, we created two dominant negative forms of XTIF2. Overexpression of both dominant negatives, dominant negative N (DNN) encompassing the NR interacting domain, and dominant negative C (DNC) which contains the CBP-binding region, caused loss of head structures and reduction of the trunk and open blastopores, although to different extents. This is probably due to differences in the stability of the truncated proteins, as suggested by the visualization of the Myc marker. The speci®city of these effects was shown by the capability of full-length XTIF2 but not XSRC-3, another Xenopus cofactor from the p160 family (Han-Jong et al., 1998) , to rescue to a larger extent the defects caused by the overexpression of both dominant negative proteins. However, it is still possible that overexpression of these dominant negative XTIF2 mRNAs is interfering with other p160 cofactor(s) that can be replaced by XTIF2 but not XSRC-3.
Upon overexpression, both dominant negatives caused ectopic transcription of Xbra and XMyoD, and ectopic expression from an Xbra mesoderm enhancer construct in the ectoderm, dorsal mesoderm and endoderm. Overexpression of a hormone-inducible form of Xbra causes ectopic muscle formation (Tada et al., 1997) . Thus, the ectopic XMyoD mRNA observed in the XTIF2 dominant negativeinjected embryos could be due to the activation of Xbra. Alternatively, ectopic XMyoD expression could be induced independently of Xbra. XTIF2 mRNA, in early stages (late blastula±early gastrula), is distributed homogeneously, and interference with XTIF2 function causes ectopic expression of Xbra in all three tissue layers and even in animal caps. It is possible that the pathway in which XTIF2 participates is required to keep Xbra repressed. The fact that overexpression of DNN or DNC, which should interfere with binding of XTIF2 to a NR or CBP, respectively, caused ectopic appearance of Xbra mRNA indicates that the pathway that represses Xbra requires a NR and CBP, and XTIF2 could be necessary to bring CBP to the ligand-bound NR. Thus, Xbra activation could take place in those regions where XTIF2 pathway is inactive (for example, if the NR, ligand or CBP are absent in those territories) or by interference with this pathway. Since, upon ligand binding, NRs recruit cofactors such as TIF2 and CBP to activate transcription (reviewed in Freedman (1999) ; Xu et al. (1999) ), the ectopic Xbra mRNA observed in embryos where this pathway is interrupted is probably due to the repression (or non activation) of a factor(s) necessary to repress Xbra. Indeed, it has been proposed that the pattern of Xbra expression could be, at least in part, due to relief of repression (Verschueren et al., 1999) . SIP1, a novel zinc ®nger/homeodomain molecule, binds to the Xbra mesoderm enhancer and its overexpression in Xenopus embryos downregulates Xbra transcription. SIP1 binding sites in the Xbra enhancer are necessary for correct spatial and temporal expression of this gene. These sites map to a region of the enhancer required for activin response. Since SIP1 interacts with activated Smad proteins, it is possible that upon TGF-b (transforming growth factor b ) signalling, Smads are activated by phosphorylation, interact with SIP1 and consequently release SIP1 repression of Xbra (Verschueren et al., 1999) . SIP1 has not yet been identi®ed in Xenopus. However, it is possible that XTIF2 participates in the positive regulation of SIP1. The XTIF2 dominant negatives would then downregulate SIP1 and thus release repression of Xbra, causing its ectopic transcriptional activation.
At late gastrula and onwards, XTIF2 mRNA is most abun- dant in the notochord, a territory which also expresses Xbra. Why does XTIF2 not repress Xbra in this territory? Since the enhancer(s) responsible for Xbra expression in the notochord is (are) different from that necessary for Xbra expression in the remaining mesoderm, XTIF2 may not affect the ®rst one(s). What could then be the XTIF2 function in the notochord? In embryos injected with DNC, but not with DNN, Xlim1 and pintallavis are repressed and notochord formation is impaired. Thus, XTIF2 may be necessary for notochord formation through a pathway that requires CBP but not a NR. However, it cannot be ruled out that DNN may not interfere strongly enough with XTIF2 function due to the low stability of this dominant negative protein.
XTIF2 and mesoendoderm formation
Overexpression of DNC, and to a lesser extent DNN, caused truncation of anterior structures. XTIF2 is expressed in the head region beginning at the neurula stage. In addition, it is also expressed in the prospective head mesoderm at the early gastrula stages. We have found that XTIF2 is necessary for the expression of several dorsal mesoderm and endoderm genes, since overexpression of DNC represses chd, cer, Xotx2, gsc, Mix.1 and edd, genes known to be necessary for head development (Rosa, 1989; Cho et al., 1991; Sasai et al., 1994; Blitz and Cho, 1995; Pannese et al., 1995; Bouwmeester et al., 1996; Sasai et al., 1996; Lemaire et al., 1998) . Recently, it has been shown that Mix.1 is required for edd and cer expression, and it is repressed by Xbra (Lemaire et al., 1998) . Thus, repression of edd, cer and Mix.1 in embryos injected with DNC could result from Xbra overexpression and its effect on Mix.1. Moreover, inhibition of the function of gsc or Mix.1 leads to transient ectopic Xbra expression and anterior defects (Latinkic and Smith, 1999) . Thus, the anterior defects could be due solely to Xbra overexpression. However, it has been found that overexpression of Xbra does not repress gsc (Artinger et al., 1997) . Therefore, the repression of dorsal mesoderm and endoderm genes in embryos injected with DNC mRNA could not solely be due to the ectopic Xbra expression. These data, and the repression of Xlim1 and pintallavis in embryos injected with DNC mRNA, suggest that the XTIF2 pathway is necessary for dorsal mesoderm and endoderm gene expression. Thus, the defects observed in embryos injected with DNC are probably due to interference with several processes, among them repression of Xbra and activation of dorsal mesoderm and endoderm genes, by XTIF2. Some of these processes may require a NR and others may not. This could explain the different phenotypes in embryos injected with DNN or DNC mRNAs.
